These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3117828)

  • 21. Evaluation of routine anti-HBc screening of volunteer blood donors: a questionable surrogate test for non-A, non-B hepatitis.
    Hanson MR; Polesky HF
    Transfusion; 1987; 27(1):107-8. PubMed ID: 3101245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of transmission of hepatitis B, hepatitis C and human immunodeficiency virus infections through blood transfusion by anti-HBc testing.
    Busch MP
    Vox Sang; 1998; 74 Suppl 2():147-54. PubMed ID: 9704438
    [No Abstract]   [Full Text] [Related]  

  • 23. [Prevention of non-A non-B hepatitis in Guadeloupe].
    Fest T; Gordien E; Neubauer J; Citadelle E; Agis F
    Rev Fr Transfus Hemobiol; 1989 Dec; 32(6):483-4. PubMed ID: 2517013
    [No Abstract]   [Full Text] [Related]  

  • 24. Post-transfusion non-A, non-B hepatitis after cardiac surgery. Prospective analysis of donor blood anti-HBc antibody as a predictive indicator of the occurrence of non-A, non-B hepatitis in recipients.
    Aymard JP; Janot G; Gayet S; Guillemin C; Canton P; Gaucher P; Streiff F
    Vox Sang; 1986; 51(3):236-8. PubMed ID: 3101289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.
    Alter HJ; Purcell RH; Shih JW; Melpolder JC; Houghton M; Choo QL; Kuo G
    N Engl J Med; 1989 Nov; 321(22):1494-500. PubMed ID: 2509915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Should donor blood be screened for elevated alanine aminotransferase levels? A cost-effectiveness analysis.
    Silverstein MD; Mulley AG; Dienstag JL
    JAMA; 1984 Nov 23-30; 252(20):2839-45. PubMed ID: 6436522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of screening tests for transfusion-associated non-A non-B hepatitis.
    Fleurette F; Durieux P; Battista RN; Benhamou JP; Degos F; Brechot C; Courouce AM; Janot C; Trepo C
    Int J Technol Assess Health Care; 1993; 9(4):479-89. PubMed ID: 7507096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Contribution to the task of reducing the incidence of post transfusion non-A, non-B hepatitis].
    Hernández Sánchez MC; Vila Enriquez P; Alvarez Hernández M
    Sangre (Barc); 1989 Jun; 34(3):248-9. PubMed ID: 2503897
    [No Abstract]   [Full Text] [Related]  

  • 29. Transmission of serologically silent hepatitis B virus along with hepatitis C virus in two cases of posttransfusion hepatitis.
    Baginski I; Chemin I; Hantz O; Pichoud C; Jullien AM; Chevre JC; Li JS; Vitvitski L; Sninsky JJ; Trepo C
    Transfusion; 1992; 32(3):215-20. PubMed ID: 1557801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
    Chung HT; Lee JS; Lok AS
    Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of screening for hepatitis C virus antibody and hepatitis B virus core antibody on incidence of post-transfusion hepatitis. Japanese Red Cross Non-A, Non-B Hepatitis Research Group.
    Lancet; 1991 Oct; 338(8774):1040-1. PubMed ID: 1681356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Anti-HVC and blood donors. Epidemiologic study of anti-HVC antibodies and the relation to indirect markers (ALT, anti-HBc)].
    Janot C
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):347-50. PubMed ID: 2177596
    [No Abstract]   [Full Text] [Related]  

  • 33. Rationale for surrogate testing to detect non-A, non-B hepatitis.
    Menitove JE
    Transfus Med Rev; 1988 Jun; 2(2):65-75. PubMed ID: 2980081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-transfusion non-A, non-B hepatitis: significance of raised ALT and anti-HBc in blood donors.
    Gillon J; Hussey AJ; Howe SP; Beckett GJ; Prescott RJ
    Vox Sang; 1988; 54(3):148-53. PubMed ID: 3130726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-A, non-B hepatitis surrogate testing of blood donations.
    Lancet; 1987 Jun; 1(8546):1366-7. PubMed ID: 2884466
    [No Abstract]   [Full Text] [Related]  

  • 36. [Prevalence of antibodies to hepatitis C (anti HCV) in blood donors in Rio de Janeiro, Brazil. Its relation to ALT and anti HBC].
    Leite NC; Nogueira CM; Coelho HS; Perez R; Martins SJ; Soares JA; Junqueira PC
    Arq Gastroenterol; 1992; 29(1):5-11. PubMed ID: 1307202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis with isolated serum antibody to hepatitis B core antigen. A variant of non-A, non-B hepatitis?
    Lai KN; Lai FM; Leung NW; Lo ST; Tam JS
    Am J Clin Pathol; 1990 Jan; 93(1):79-83. PubMed ID: 2104740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Sreening of blood for antibody to hepatitis B virus core antigen and prevention of post-transfusional hepatitis C before 1990].
    Echevarría Mayo JM; León Rega P
    Med Clin (Barc); 2003 Mar; 120(10):397. PubMed ID: 12681107
    [No Abstract]   [Full Text] [Related]  

  • 39. Cost-effectiveness of screening blood donors for hepatitis C and non-A, non-B, non-C hepatitis. The EATHIS Eco Research Group. European Acute Transfusion Hepatitis Interferon Study.
    Colin C; Vergnon P; Jullien AM; Excoffier S; Matillon Y; Trepo C
    Eur J Clin Microbiol Infect Dis; 1997 Mar; 16(3):220-7. PubMed ID: 9131325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antibodies to hepatitis B core antigen in blood donors and hepatitis non-A, non-B in blood recipients].
    Sugg U
    Beitr Infusionsther; 1988; 21():177-81. PubMed ID: 2462972
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.